Cyclerion Therapeutics (CYCN) Financial Statements

266 Followers

Cyclerion Therapeutics Financial Overview

Cyclerion Therapeutics's market cap is currently $12.69M. The company's EPS TTM is $; its P/E ratio is -1.16; Cyclerion Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 2.07M	$ 2.00M	$ 0.00	$ 297.00K	$ 3.32M
Gross Profit	$ 2.07M	$ 2.00M	$ 0.00	$ -5.28M	$ 3.32M
Operating Income	$ -4.97M	$ -3.63M	$ -12.95M	$ -18.54M	$ -55.20M
EBITDA	$ -4.97M	$ -3.63M	$ -9.58M	$ -18.48M	$ -53.84M
Net Income	$ -3.53M	$ -3.06M	$ -5.26M	$ -44.08M	$ -51.65M
Balance Sheet
Cash & Short-Term Investments	$ 3.24M	$ 3.23M	$ 7.57M	$ 13.38M	$ 53.96M
Total Assets	$ 9.98M	$ 9.57M	$ 13.37M	$ 18.08M	$ 59.33M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -3.24M	$ -3.23M	$ -7.57M	$ -13.38M	$ -53.96M
Total Liabilities	$ 900.00K	$ 725.00K	$ 2.09M	$ 7.63M	$ 11.09M
Stockholders' Equity	$ 9.09M	$ 8.85M	$ 11.29M	$ 10.45M	$ 48.25M
Cash Flow
Free Cash Flow	$ -3.31M	$ -4.33M	$ -21.25M	$ -40.61M	$ -36.52M
Operating Cash Flow	$ -3.31M	$ -4.33M	$ -21.25M	$ -40.61M	$ -36.52M
Investing Cash Flow	$ 0.00	$ 0.00	$ 10.40M	$ 0.00	$ 1.46M
Financing Cash Flow	$ 3.32M	$ 0.00	$ 5.02M	$ 29.00K	$ 30.79M

Currency in USD

Cyclerion Therapeutics Earnings and Revenue History

Income Statement >

Cyclerion Therapeutics Debt to Assets

Balance Sheet >

Cyclerion Therapeutics Cash Flow

Cash Flow >

Cyclerion Therapeutics Forecast EPS vs Actual EPS

Earnings >